---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-001911"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:38:26.902714+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# KALA BIO launches AI infrastructure platform; licenses Researgency from Younet AI

## Summary
- Exclusive worldwide license to Researgency platform for biotech field; initial 12-month term with renewal options.
- Consideration includes up to $530k cash and issuance of 5 million shares of KALA common stock per term.
- Company holds an irrevocable option to acquire Younet AI for $55 million, exercisable during the term.
- Strategic pivot: KALA will deploy on-premises, data-sovereign AI for biotech clients targeting recurring revenue.
- KALA will first deploy on its own MSC-S and KPI-012 data; preliminary findings expected in 12 months.

## SEC filing metadata
- accession: 0001829126-26-001911
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 3.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/0001829126-26-001911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000182912626001911/kalabio_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-001911
- JSON: https://secwatch.observer/filing/0001829126-26-001911.json
- Plain text: https://secwatch.observer/filing/0001829126-26-001911.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.